NASDAQ:VYGR Voyager Therapeutics Q2 2026 Earnings Report $2.68 -0.12 (-4.29%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$2.76 +0.08 (+3.13%) As of 09/25/2026 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Voyager Therapeutics EPS ResultsActual EPS-$0.40Consensus EPS -$0.48Beat/MissBeat by +$0.08One Year Ago EPSN/AVoyager Therapeutics Revenue ResultsActual Revenue$3.17 millionExpected Revenue$4.52 millionBeat/MissMissed by -$1.35 millionYoY Revenue GrowthN/AVoyager Therapeutics Announcement DetailsQuarterQ2 2026Date8/6/2026TimeAfter Market ClosesConference Call DateThursday, August 6, 2026Conference Call Time7:00AM ETUpcoming EarningsVoyager Therapeutics' Q3 2026 earnings is estimated for Monday, November 9, 2026, based on past reporting schedules, with a conference call scheduled on Friday, November 6, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Voyager Therapeutics Earnings HeadlinesVoyager Therapeutics (NASDAQ:VYGR) Stock Breaks Below 50-Day Moving Average - Time to Sell?September 26 at 3:41 AM | americanbankingnews.comAnalyzing Onconetix (NASDAQ:ONCO) & Voyager Therapeutics (NASDAQ:VYGR)September 22, 2026 | americanbankingnews.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.September 27 at 1:00 AM | Banyan Hill Publishing (Ad)Voyager Therapeutics, Inc. (VYGR) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeptember 10, 2026 | seekingalpha.comVoyager to Present at Upcoming Investor ConferencesSeptember 1, 2026 | globenewswire.comTD Cowen Remains a Buy on Voyager Therapeutics (VYGR)August 24, 2026 | theglobeandmail.comSee More Voyager Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Voyager Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Voyager Therapeutics and other key companies, straight to your email. Email Address About Voyager TherapeuticsVoyager Therapeutics (NASDAQ:VYGR) (NASDAQ: VYGR) is a clinical-stage biotechnology company focused on developing gene therapies and other medicines for diseases of the central nervous system. The company seeks to address neurological conditions by delivering therapeutic genetic material to specific cells in the brain and spinal cord. Voyager’s technology platform includes its TRACER AAV capsid discovery platform, which is designed to identify adeno-associated virus capsids that can cross the blood-brain barrier and enable broader distribution of gene therapies. Its research and development programs have targeted conditions including Huntington’s disease, Parkinson’s disease and other neurodegenerative disorders. Founded in 2013 and headquartered in Cambridge, Massachusetts, Voyager has advanced its programs through internal development and collaborations with pharmaceutical companies, including partnerships involving neurological gene therapy candidates. The company’s operations are primarily focused on biotechnology research, preclinical studies and clinical development, with activities conducted through its U.S. organization and strategic collaborators.View Voyager Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/252 Cybersecurity Stocks Breaking Out as AI Continues to Be a TailwindCostco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem5 Scary-Good Stocks With Strong October Catalysts and Breakout PotentialDarden Restaurants Serves Up Fresh Catalysts for a Stock Price RallySoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
